Retatrutide 10 mg | Research-Grade Peptide | GIP, GLP-1 & Glucagon Triple Receptor Agonist

Retatrutide is an investigational peptide compound designed to interact with three metabolic signaling pathways: GIP, GLP-1, and glucagon receptors. Its unique triple-receptor activity has made it a compound of significant interest in ongoing metabolic research.

Each vial contains 10 mg of Retatrutide, prepared for laboratory research applications where consistency, accurate identification, and controlled handling are essential.